|
1
|
Perez F, Hujer AM, Hujer KM, Decker BK,
Rather PN and Bonomo RA: Global challenge of multidrug-resistant
Acinetobacter baumannii. Antimicrob Agents Chemother. 51:3471–3484.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giamarellou H, Antoniadou A and
Kanellakopoulou K: Acinetobacter baumannii: A universal threat to
public health? Int J Antimicrob Agents. 32:106–119. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang F, Zhu D, Hu F, Jiang X, Hu Z, Li Q,
Sun Z, Chen Z, Xu Y, Zhang X, et al: CHINET 2012 surveillance of
bacterial resistance in China. China J Infect Chemother.
13:321–330. 2013.Chinese.
|
|
4
|
Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ
and Kang MW: Risk factors for mortality in patients with
carbapenem-resistant Acinetobacter baumannii bacteremia: Impact of
appropriate antimicrobial therapy. J Korean Med Sci. 27:471–475.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Go ES, Urban C, Burns J, Kreiswirth B,
Eisner W, Mariano N, Mosinka-Snipas K and Rahal JJ: Clinical and
molecular epidemiology of acinetobacter infections sensitive only
to polymyxin B and sulbactam. Lancet. 344:1329–1332. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pournaras S, Markogiannakis A, Ikonomidis
A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ and Tsakris A:
Outbreak of multiple clones of imipenem-resistant Acinetobacter
baumannii isolates expressing OXA-58 carbapenemase in an intensive
care unit. J Antimicrob Chemother. 57:557–561. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuo LC, Teng LJ, Yu CJ, Ho SW and Hsueh
PR: Dissemination of a clone of unusual phenotype of
pandrug-resistant Acinetobacter baumannii at a university hospital
in Taiwan. J Clin Microbiol. 42:1759–1763. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu J, Sun Z, Li Y and Zhou Q: Surveillance
and correlation of antibiotic consumption and resistance of
Acinetobacter baumannii complex in a tertiary care hospital in
northeast China, 2003–2011. Int J Environ Res Public Health.
10:1462–1473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwon NY, Kim JD and Pai HJ: The resistance
mechanisms of b-lactam antimicrobials in clinical isolates of
Acinetobacter baumannii. Korean J Intern Med. 17:94–99. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
García-Quintanilla M, Pulido MR,
Moreno-Martínez P, Martín-Peña R, López-Rojas R, Pachón J and
McConnell MJ: Activity of host antimicrobials against
multidrug-resistant Acinetobacter baumannii acquiring colistin
resistance through loss of lipopolysaccharide. Antimicrob Agents
Chemother. 58:2972–2975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen TL, Siu LK, Wu RC, Shaio MF, Huang
LY, Fung CP, Lee CM and Cho WL: Comparison of one-tube multiplex
PCR, automated ribotyping and intergenic spacer (ITS) sequencing
for rapid identification of Acinetobacter baumannii. Clin Microbiol
Infect. 13:801–806. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clinical Laboratory Standards Institute
(CLSI): Performance standards for antimicrobial susceptibility
testing; Twenty-second informational supplement. CLSI document
M100-S22. CLSI; Wayne, PA: 2012
|
|
13
|
Zhang JP, Zhu W, Tian SF, Chu YZ and Chen
BY: Molecular characteristics and resistant mechanisms of
imipenem-resistant Acinetobacter baumannii isolates in Shenyang.
China J Microbiol. 48:689–694. 2010. View Article : Google Scholar
|
|
14
|
Merkier AK and Centrón D: bla(OXA-51)-type
beta-lactamase genes are ubiquitous and vary within a strain in
Acinetobacter baumannii. Int J Antimicrob Agents. 28:110–113. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He C, Xie Y, Zhang L, Kang M, Tao C, Chen
Z, Lu X, Guo L, Xiao Y, Duo L, et al: Increasing imipenem
resistance and dissemination of the ISAba1-associated blaOXA-23
gene among Acinetobacter baumannii isolates in an intensive care
unit. J Med Microbiol. 60:337–341. 2011. View Article : Google Scholar
|
|
16
|
Martínez P and Mattar S:
Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla
OXA-23,51 and ISAba1-bla ADC-7 genes in Monteria, Colombia. Braz J
Microbiol. 43:1274–1280. 2012. View Article : Google Scholar
|
|
17
|
Corvec S, Poirel L, Naas T, Drugeon H and
Nordmann P: Genetics and expression of the carbapenem-hydrolyzing
oxacil-linase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob
Agents Chemother. 51:1530–1533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yong D, Toleman MA, Giske CG, Cho HS,
Sundman K, Lee K and Walsh TR: Characterization of a new
metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin
esterase gene carried on a unique genetic structure in Klebsiella
pneumoniae sequence type 14 from India. Antimicrob Agents
Chemother. 53:5046–5054. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cabanes F, Lemant J, Picot S, Simac C,
Cousty J, Jalin L, Naze F, Boisson V, Cresta MP, André H, et al:
Emergence of Klebsiella pneumoniae and Salmonella
metallo-beta-lactamase (NDM-1) producers on reunion island. J Clin
Microbiol. 50:38122012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Savard P, Gopinath R, Zhu W, Kitchel B,
Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, et al:
First NDM-positive Salmonella sp. strain identified in the United
States. Antimicrob Agents Chemother. 55:5957–5958. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jovcic B, Lepsanovic Z, Suljagic V, Rackov
G, Begovic J, Topisirovic L and Kojic M: Emergence of NDM-1
metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates
from Serbia. Antimicrob Agents Chemother. 55:3929–3931. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poirel L, Dortet L, Bernabeu S and
Nordmann P: Genetic features of blaNDM-1-positive
Enterobacteriaceae. Antimicrob Agents Chemother. 55:5403–5407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ho PL, Lo WU, Yeung MK, Lin CH, Chow KH,
Ang I, Tong AH, Bao JY, Lok S and Lo JY: Complete sequencing of
pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant
Escherichia coli strain isolated in Hong Kong. PLoS One.
6:e179892011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chu YW, Chau SL and Houang ET: Presence of
active efflux systems AdeABC, AdeDE and AdeXYZ in dierent AbeM
(MATE) Ade ABC Acinetobacter genomic DNA groups. J Med Microbiol.
55:477–478. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marchand I, Damier-Piolle L, Courvalin P
and Lambert T: Expression of the RND-type efflux pump AdeABC in
Acineto-bacter baumannii is regulated by the AdeRS two-compo nent
system. Antimicrob Agents Chemother. 48:3298–3304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mussi MA, Limansky AS and Viale AM:
Acquisition of resistance to carbapenems in multidrug-resistant
clinical strains of Acinetobacter baumannii: Natural insertional
inactivation of a gene encoding a member of a novel family of
β-barrel outer membrane proteins. Antimicrob Agents Chemother.
49:1432–1440. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Z, Du X, Wang L, Yang Q, Fu Y and Yu
Y: Clinical carbapenem-resistant Acinetobacter baylyi strain
coharboring blaSIM-1 and blaOXA-23 from China. Antimicrob Agents
Chemother. 55:5347–5349. 2011. View Article : Google Scholar : PubMed/NCBI
|
